Mild Ischemic Mitral Regurgitation: Is Revascularization Enough for Every Patient?
Keywords:mitral valve replacement, mitral regurgitation, subvalvular
Background: The progress of mild ischemic mitral regurgitation (MR) after isolated coronary artery bypass is not clear. We aimed to determine the proportion of patients with mild ischemic MR undergoing isolated coronary artery bypass grafting (CABG) presenting with regression of or persistent MR one year after CABG and to identify the significantly different echocardiographic variables between regressing and persistent MR.
Methods: Sixty-three patients with preoperative mild ischemic MR were categorized into an MR-
regression or an MR-persistence group one year after isolated CABG. The echocardiographic indices, indicating mitral leaflet configuration and remodeling of the left ventricle (LV), were measured before and one year after
Results: One year after CABG, MR regressed in 60% (38/63) and persisted in 40% (25/63) of the patients. The left ventricular diameter, volume, and sphericity and anteroposterior diameter of the mitral annulus improved only in the MR-regression group, while the ejection fraction improved in both groups (47.7% ± 12.4% from 40.1% ± 11.3%,
P < .001 in the regression group and 43.2% ± 14.0% from 39.3% ± 11.6%, P = .035 in the persistence group). A >15% decrease in the LV end-systolic volume was noted more frequently in the MR-regression group (60.5% versus 30%,
P = .027). The leaflet angle did not show asymmetry or significant changes in both groups.
Conclusions: Isolated CABG improved mild MR in most patients with mild ischemic MR. These patients showed greater reverse remodeling after revascularization than the patients with persistent MR after isolated CABG. Additional tests, which can predict LV reverse remodeling, are needed to predict persistent MR.
Acker MA, Parides MK, Perrault LP, et al. 2014. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. The New England journal of medicine. 370(1):23-32.
Agricola E, Oppizzi M, Maisano F, et al. 2004. Echocardiographic classification of chronic ischemic mitral regurgitation caused by restricted motion according to tethering pattern. European journal of echocardiography: the journal of the Working Group on Echocardiography of the European Society of Cardiology. 5(5):326-334.
Aronson D, Goldsher N, Zukermann R, et al. 2006. Ischemic mitral regurgitation and risk of heart failure after myocardial infarction. Archives of internal medicine. 166(21):2362-2368.
D'Agostino RS, Jacobs JP, Badhwar V, et al. 2018. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2018 Update on Outcomes and Quality. The Annals of thoracic surgery. 105(1):15-23.
Dal-Bianco JP, Aikawa E, Bischoff J, et al. 2009. Active adaptation of the tethered mitral valve: insights into a compensatory mechanism for functional mitral regurgitation. Circulation. 120(4):334-342.
Feinberg MS, Schwammenthal E, Shlizerman L, et al. 2000. Prognostic significance of mild mitral regurgitation by color Doppler echocardiography in acute myocardial infarction. The American journal of cardiology. 86(9):903-907.
Goldstein D, Moskowitz AJ, Gelijns AC, et al. 2016. Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. The New England journal of medicine. 374(4):344-353.
Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. 2001. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 103(13):1759-1764.
He S, Fontaine AA, Schwammenthal E, Yoganathan AP, Levine RA. 1997. Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies. Circulation. 96(6):1826-1834.
Hsuan CF, Yu HY, Tseng WK, Lin LC, Hsu KL, Wu CC. 2013. Quantitation of the mitral tetrahedron in patients with ischemic heart disease using real-time three-dimensional echocardiography to evaluate the geometric determinants of ischemic mitral regurgitation. Clinical cardiology. 36(5):286-292.
Hung J, Solis J, Handschumacher MD, Guerrero JL, Levine RA. 2012. Persistence of mitral regurgitation following ring annuloplasty: is the papillary muscle outside or inside the ring? The Journal of heart valve disease. 21(2):218-224.
Ji Q, Zhao Y, Shen J, et al. 2019. Risk Factors for Moderate or More Residual Regurgitation in Patients with Moderate Chronic Ischemic Mitral Regurgitation Undergoing Surgical Revascularization Alone. Int Heart J. 60(6):1268-1275.
Kono T, Sabbah HN, Rosman H, Alam M, Jafri S, Goldstein S. 1992. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. Journal of the American College of Cardiology. 20(7):1594-1598.
Kuwahara E, Otsuji Y, Iguro Y, et al. 2006. Mechanism of recurrent/persistent ischemic/functional mitral regurgitation in the chronic phase after surgical annuloplasty: importance of augmented posterior leaflet tethering. Circulation. 114(1 Suppl):I529-534.
Kwan J, Shiota T, Agler DA, et al. 2003. Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation: real-time three-dimensional echocardiography study. Circulation. 107(8):1135-1140.
Lehmann KG, Francis CK, Dodge HT. 1992. Mitral regurgitation in early myocardial infarction. Incidence, clinical detection, and prognostic implications. TIMI Study Group. Annals of internal medicine. 117(1):10-17.
Magne J, Pibarot P, Dagenais F, Hachicha Z, Dumesnil JG, Senechal M. 2007. Preoperative posterior leaflet angle accurately predicts outcome after restrictive mitral valve annuloplasty for ischemic mitral regurgitation. Circulation. 115(6):782-791.
McGee EC, Gillinov AM, Blackstone EH, et al. 2004. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. The Journal of thoracic and cardiovascular surgery. 128(6):916-924.
Meris A, Amigoni M, Verma A, et al. 2012. Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarction. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 25(5):535-542.
Michler RE, Smith PK, Parides MK, et al. 2016. Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation. The New England journal of medicine. 374(20):1932-1941.
Nesta F, Otsuji Y, Handschumacher MD, et al. 2003. Leaflet concavity: a rapid visual clue to the presence and mechanism of functional mitral regurgitation. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 16(12):1301-1308.
Nishimura RA, Otto CM, Bonow RO, et al. 2017. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 135(25):e1159-e1195.
Otsuji Y, Handschumacher MD, Schwammenthal E, et al. 1997. Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. Circulation. 96(6):1999-2008.
Otsuji Y, Kumanohoso T, Yoshifuku S, et al. 2002. Isolated annular dilation does not usually cause important functional mitral regurgitation: comparison between patients with lone atrial fibrillation and those with idiopathic or ischemic cardiomyopathy. Journal of the American College of Cardiology. 39(10):1651-1656.
Penicka M, Linkova H, Lang O, et al. 2009. Predictors of improvement of unrepaired moderate ischemic mitral regurgitation in patients undergoing elective isolated coronary artery bypass graft surgery. Circulation. 120(15):1474-1481.
Sabbah HN, Kono T, Stein PD, Mancini GB, Goldstein S. 1992. Left ventricular shape changes during the course of evolving heart failure. The American journal of physiology. 263(1 Pt 2):H266-270.
Sabbah HN, Rosman H, Kono T, Alam M, Khaja F, Goldstein S. 1993. On the mechanism of functional mitral regurgitation. The American journal of cardiology. 72(14):1074-1076.
Salmasi MY, Harky A, Chowdhury MF, et al. 2018. Should the mitral valve be repaired for moderate ischemic mitral regurgitation at the time of revascularization surgery? J Card Surg. 33(7):374-384.
Smith PK, Puskas JD, Ascheim DD, et al. 2014. Surgical treatment of moderate ischemic mitral regurgitation. The New England journal of medicine. 371(23):2178-2188.
Tibayan FA, Rodriguez F, Zasio MK, et al. 2003. Geometric distortions of the mitral valvular-ventricular complex in chronic ischemic mitral regurgitation. Circulation. 108 Suppl 1:Ii116-121.Zeng X, Nunes MC, Dent J, et al. 2014. Asymmetric versus symmetric tethering patterns in ischemic mitral regurgitation: geometric differences from three-dimensional transesophageal echocardiography. Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography. 27(4):367-375.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).